Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Antidepressants and Driving Ability]

Alexander Brunnauer1, Gerd Laux

  • 1Bezirksklinikum Gabersee, Fachkrankenhaus für Psychiatrie, Psychotherapie und Neurologie, Abteilung Neuropsychologie. Brunnauer.Alexander@gabersee.de

Psychiatrische Praxis
|September 18, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2026 - Pharmacokinetic, pharmacogenetic and clinical aspects.

Pharmacopsychiatry·2026
Same author

[Mental diseases and driving ability-An update].

Der Nervenarzt·2026
Same author

Case Report: Effect of medicinal cannabis on fitness to drive in a patient with Tourette Syndrome and ADHD.

Frontiers in psychiatry·2025
Same author

The impact of aerobic endurance training on cognitive performance in schizophrenic inpatients in a clinical routine setting.

European archives of psychiatry and clinical neuroscience·2024
Same author

The Effect of Nabiximols on Driving Ability in Adults with Chronic Tic Disorders: Results of a Substudy Analysis of the Double-Blind, Randomized, Placebo-Controlled CANNA-TICS Trial.

Cannabis and cannabinoid research·2024
Same author

Driving-related cognitive skills during antidepressant transcranial direct current stimulation: results in a subsample from the DepressionDC trial.

Frontiers in psychiatry·2023
Same journal

[Weight-related nutritional interventions for people with mental illness in psychiatric clinics in Germany].

Psychiatrische Praxis·2026
Same journal

[Interdisciplinary Collaboration between Social Service and Case Management in Child and Adolescent Psychiatry: A Qualitative Study of Barriers, Facilitators and the Family Caregiver Perspective].

Psychiatrische Praxis·2026
Same journal

[Work with People with Intellectual Disabilities and Challenging Behavior: Resources, Stressors, and Organizational Approaches].

Psychiatrische Praxis·2026
Same journal

[When IPS Coaching isn't always effective: Findings from the German IPS-ZIB Project].

Psychiatrische Praxis·2026
Same journal

[Borderline personality disorder as a severe mental illness: results of an empirical study].

Psychiatrische Praxis·2026
Same journal

[Firearm Suicides In Switzerland From 1969 To 2023].

Psychiatrische Praxis·2026
See all related articles

Depression impairs driving ability. Newer antidepressants may offer better psychomotor function for driving than older tricyclic antidepressants, suggesting careful medication selection is crucial.

Area of Science:

  • Psychopharmacology
  • Neuroscience
  • Traffic Safety

Background:

  • Depression significantly impacts cognitive functions, including psychomotor skills essential for driving.
  • Assessing the driving capabilities of patients undergoing antidepressant treatment is critical for public safety.

Purpose of the Study:

  • To evaluate the effect of antidepressant medications on the psychomotor performance of individuals with depression.
  • To compare the impact of newer antidepressants versus tricyclic antidepressants on driving-related abilities.

Main Methods:

  • Sixty-four depressive inpatients were assessed under steady-state plasma drug levels.
  • The Act and React Testsystem (ART 90) was used to measure visual perception, reactivity, stress tolerance, selective attention, and vigilance.

Related Experiment Videos

  • Data were analyzed based on medication type, illness severity, and patient age.

    • Main Results:

    • A significant majority (76.2%) of patients did not meet the performance criteria compared to normal controls.
    • Patients treated with newer antidepressants demonstrated superior psychomotor performance compared to those on tricyclic antidepressants.
    • Performance was analyzed in relation to medication, illness severity, and age.

    Conclusions:

    • Depressive patients often exhibit impaired psychomotor function, affecting driving ability.
    • Newer antidepressants appear to have more favorable effects on psychomotor function relevant to driving compared to tricyclic antidepressants.
    • Systematic assessment of driving ability is recommended for patients with depression.